CONNECT WITH US
Tech

Tech

Utah will become first state to let AI examine patients and prescribe medication without direct human oversight

TechSpot logo

Published on

Add as a preferred source on Google
Utah will become first state to let AI examine patients and prescribe medication without direct human oversight

A hot potato: Being a doctor is one of the jobs expected to be least at risk from AI replacement. But a new program launched in Utah is raising questions over that assumption. A healthcare startup will begin offering AI examinations and prescriptions to patients without direct human oversight, making Utah the first state to replace a doctor with an AI.

The good news is that the program is currently very limited in its scope. It's just one year long and only for patients with mild-to-moderate acne.

The process works when a person signs up for Nolla Health's $4.99-per-month app and uses it to scan their face. After completing a medical history and personal information form, the AI analyzes their skin, identifies the acne problem, rates the skin's oiliness, and then generates a numerical acne severity score that ranges between clear skin and severe acne, reports Bloomberg.

The AI then combines that score with the provided medical information to recommend medication from a list of eight approved treatments.

While the program will eventually become fully automated, the first 100 prescriptions will have to be reviewed by actual doctors before they are submitted to the pharmacy.

In the second phase, the next 400 patients will have their prescriptions submitted to pharmacies by the AI and reviewed retrospectively by a physician weekly.

The final phase will involve a doctor reviewing at least 10% of the total prescriptions issued once a month.

We've repeatedly seen the dangers of putting your trust in AI when it comes to medical/healthcare advice.


Source link
Related Topics:Tech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.